the use of tafasitamab and lenalidomide in r/r dlbcl
Published 1 year ago • 217 plays • Length 1:36Download video MP4
Download video MP3
Similar videos
-
1:17
the latest updates on tafasitamab in dlbcl
-
1:41
real-world efficacy of tafasitamab lenalidomide in r/r dlbcl & the importance of patient selection
-
1:09
tafasitamab for r/r dlbcl
-
2:50
tafasitamab-lenalidomide in r/r dlbcl: clinical trial results and real-world data
-
1:30
the role of tafasitamab in the lymphoma treatment landscape & promising results from clinical trials
-
2:15
frontmind: tafasitamab lenalidomide r-chop vs r-chop for newly diagnosed high-risk dlbcl
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
1:45
the role of non-covalent btkis in the era of covalent btkis for b-cell malignancies
-
19:46
precision medicine in follicular lymphoma
-
55:54
management of peripheral t-cell lymphoma
-
30:04
yunhe li: segmentation of lymphoma in pet/ct images
-
1:58
ash highlights: glofitamab in dlbcl & pirtobrutinib and epcoritamab in richter's transformation
-
1:33
zamtocabtagene autoleucel for the treatment of patients with r/r dlbcl
-
0:42
targeted therapies for dlbcl treatment
-
4:31
updates in bispecifics for dlbcl from ash: glofitamab, odronextamab, epcoritamab & mosunetuzumab
-
1:15
dr. abdulhaq on the safety profile of tafasitamab in dlbcl
-
2:53
results from a phase i study of rapcabtagene autoleucel (ytb323), a novel car-t therapy in dlbcl
-
1:15
hello tellomak: new trial for t-cell lymphoma
-
0:54
the role of cd4 t-cells in the pathogenesis of hodgkin lymphoma
-
1:27
improving ttd for cbcl
-
2:31
long-term follow up of study of obinutuzumab, polatuzumab vedotin, and lenalidomide in r/r fl
-
5:44
glofitamab and obinutuzumab in r/r mcl